Australian Urology Associates Trials

Australian Urology Associates	Welcome, Profile Billing Logout

Australian Urology Associates

Welcome, Profile Billing Logout

3 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Grummet, Jeremy

BCG+MMC, NCT02948543: Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer

Active, not recruiting

501

Europe, RoW

Bacillus of Calmette-Guerin (BCG), OncoTICE, ImmuCYST, TheraCys, Mitomycin (MM)

University of Sydney, Australian and New Zealand Urogenital and Prostate Cancer Trials Group, Cancer Australia

Bladder Cancer

12/24

Biolen-PC, NCT04284761: A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer

Completed

US, RoW

Bicalutamide implant

Alessa Therapeutics Inc.

Prostate Adenocarcinoma, Lower Urinary Tract Symptoms

05/23

ACTRN12618001307291: Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) for intermediate-high risk prostate cancer diagnosis: The SAMURAI Trial

Recruiting

N/A

Australian Urology Associates, Monash University, Monash Biomedical Imaging

Prostate Cancer